fashion -WSS

fashion

author：leisure time 2025-08-31 20:58:31 - browse：4

Yichuan Cao/Sipa USA via AP Images

Gilead Sciences said Monday that Trodelvy, its “smart-bomb” medicine that combines an antibody with chemotherapy, did not significantly extend the lives of patients with metastatic non-small cell lung cancer when given after a first treatment failed.

The result, from a closely watched study called Evoke-01, will be seen as a disappointment by investors and oncologists alike.

Drugs like Trodelvy, known as antibody drug conjugates, are one of the hottest areas in oncology. The idea is that these medicines combine an antibody, which is triggered when it binds to a protein on a cancer cell, with a “payload” of chemotherapy that poisons the cancer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： BIO: Crackdown on China pharma industry would threaten U.S. drug supply

leisure time

WSS

Pancreatic cancer early detection could be helped by AI

FTC falls short on scrutinizing hospital mergers, study says

Pancreatic cancer early detection could be helped by AI

UnitedHealth financials solid despite Change Healthcare cyberattack

White House pharmacy plagued with problems, investigation finds

Health care needs a new profession: neuroimaging counseling

Wikipedia

fashion

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

After traumatic brain injury, life support decisions can use more time

Medical leaders decry Supreme Court decision on affirmative action

Bernie Sanders is gearing up to subpoena pharma CEOs

Medicare proposal to cover medical devices draws a mixed reaction

Bird flu outbreak in cows is latest avian flu curveball

Peter Hotez and the public health issue of online harassment

Vertex non

Medical records are filled with copy

UnitedHealth financials solid despite Change Healthcare cyberattack

Wikipedia

Medical bills so high, Medicare adding extra digits to claim forms

Vertex non

Boston competes with Raleigh

Medicare drug price negotiation legal challenge met with skepticism

H5N1 bird flu virus started spreading in cows in Texas in December

Cell therapy fails to slow type 1 diabetes, but safety is established

focus

entertainment

leisure time

leisure time